News

Can Eli Lilly Stock Withstand the Threat of President Trump's New Sweeping Tariffs?
Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...
Novartis CEO: Tariffs are an overhang on the pharmaceutical sector
CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of tariffs this year.
Fierce Pharma8h
'Hard to know what's going to happen': Big Pharmas put brave face on looming tariff threat
The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...
Trump's Latest Tariff Could Cause Medicine Shortages, Experts Say
President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.
Tariffs Are Driving Healthcare Costs Up in These States — Is Yours Affected?
Healthcare costs are already expensive for many. In some states, tariff-related price hikes are showing up in 2026 rate ...
J&J Expects Smaller Tariff Hit Than Previously Forecast; Stock Rallies
Johnson & Johnson expects a smaller hit from tariffs than it predicted earlier in the year, despite uncertainty over the prospects of new U.S. levies on pharmaceuticals. J&J now predicts tariffs will ...
US President Donald Trump Signals Tariffs On Drug And Chip Imports By Month-End, Cites National Security Concerns
Washington: US President Donald Trump has said his administration might start imposing tariffs on pharmaceutical imports at ...
200% or more? Trump hints 'very high tariffs' on pharma cos by August 1, says deal with India most likely
US President Trump had earlier suggested pharmaceutical tariffs could reach 200% after a year, incentivizing domestic manufacturing. On Tuesday, he said that an agreement with India was among the most ...